Search Results - "Brunner‐La Rocca, Hans Pieter"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
  2. 2
  3. 3

    Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial by Anker, Stefan D., Butler, Javed, Filippatos, Gerasimos S., Jamal, Waheed, Salsali, Afshin, Schnee, Janet, Kimura, Karen, Zeller, Cordula, George, Jyothis, Brueckmann, Martina, Zannad, Faiez, Packer, Milton, Packer, Milton, Anker, Stefan D., Butler, Javed, Filippatos, Gerasimos S., Zannad, Faiez, George, Jyothis, Brueckmann, Martina, Perrone, Sergio, Nicholls, Stephen, Janssens, Stefan, Bocchi, Edmar, Giannetti, Nadia, Verma, Subodh, Jian, Zhang, Gomez Mesa, Juan Esteban, Spinar, Jindrich, Böhm, Michael, Merkely, Bela, Chopra, Vijay, Senni, Michele, Taddi, Stefano, Tsutsui, Hiroyuki, Chuquiure, Eduardo, La Rocca, Hans Pieter Brunner, Ponikowski, Piotr, Vinereanu, Dragos, Sim, David, Choi, Dong‐Ju, Juanatey, Jose Ramon Gonzalez, Squire, Iain, Butler, Javed, Januzzi, James, Pina, Ileana, Pocock, Stuart J., Carson, Peter, Doehner, Wolfram, Miller, Alan, Haas, Markus, Pehrson, Steen, Komajda, Michel, Anand, Inder, Teerlink, John, Rabinstein, Alejandro, Steiner, Thorsten, Kamel, Hooman, Tsivgoulis, Georgios, Lewis, James, Freston, James, Kaplowitz, Neil, Mann, Johannes, Petrie, Mark, Bernstein, Richard, Cheung, Alfred, Green, Jennifer, Januzzi, James, Kaul, Sanjay, Ping, Carolyn Lam Su, Lip, Gregory, Marx, Nikolaus, McCullough, Peter, Mehta, Cyrus, Ponikowski, Piotr, Rosenstock, Julio, Sattar, Naveed, Scirica, Benjamin, Tsutsui, Hiroyuki, Verma, Subodh, Wanner, Christoph, Welty, Francine K., Parhofer, Klaus G., Clayton, Tim, Pedersen, Terje R., Lees, Kennedy R., Konstam, Marvin A., Greenberg, Barry, Palmer, Mike

    Published in European journal of heart failure (01-10-2019)
    “…Background The principal biological processes that characterize heart failure with a preserved ejection fraction (HFpEF) are systemic inflammation, epicardial…”
    Get full text
    Journal Article
  4. 4

    Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial by Packer, Milton, Butler, Javed, Filippatos, Gerasimos S., Jamal, Waheed, Salsali, Afshin, Schnee, Janet, Kimura, Karen, Zeller, Cordula, George, Jyothis, Brueckmann, Martina, Anker, Stefan D., Zannad, Faiez, Packer, Milton, Anker, Stefan D., Butler, Javed, Filippatos, Gerasimos, Zannad, Faiez, George, Jyothis, Brueckmann, Martina, Perrone, Sergio, Nicholls, Stephen, Janssens, Stefan, Bocchi, Edmar, Giannetti, Nadia, Verma, Subodh, Jian, Zhang, Spinar, Jindrich, Seronde, Marie‐France, Böhm, Michael, Merkely, Bela, Chopra, Vijay, Senni, Michele, Taddei, Stefano, Tsutsui, Hiroyuki, Choi, Dong‐Ju, Chuquiure, Eduardo, La Rocca, Hans Pieter Brunner, Ponikowski, Piotr, Juanatey, Jose Ramon Gonzalez, Squire, Iain, Butler, Javed, Januzzi, James, Pina, Ileana, Pocock, Stuart J., Carson, Peter, Doehner, Wolfram, Miller, Alan, Haas, Markus, Pehrson, Steen, Komajda, Michel, Anand, Inder, Teerlink, John, Rabinstein, Alejandro, Steiner, Thorsten, Kamel, Hooman, Tsivgoulis, Georgios, Lewis, James, Freston, James, Kaplowitz, Neil, Mann, Johannes, Petrie, Mark, Bernstein, Richard, Cheung, Alfred, Green, Jennifer, Januzzi, James, Kaul, Sanjay, Ping, Carolyn Lam Su, Lip, Gregory, Marx, Nikolaus, McCullough, Peter, Mehta, Cyrus, Ponikowski, Piotr, Rosenstock, Julio, Sattar, Naveed, Scirica, Benjamin, Tsutsui, Hiroyuki, Verma, Subodh, Wanner, Christoph, Welty, Francine K., Parhofer, Klaus G., Clayton, Tim, Pedersen, Terje R., Lees, Kennedy R., Konstam, Marvin A., Greenberg, Barry, Palmer, Mike

    Published in European journal of heart failure (01-10-2019)
    “…Drugs that inhibit the sodium–glucose co‐transporter 2 (SGLT2) have been shown to reduce the risk of hospitalizations for heart failure in patients with type 2…”
    Get full text
    Journal Article
  5. 5

    Empagliflozin benefits in patients with heart failure and preserved ejection fraction

    Published in Nature medicine (01-12-2022)
    “…Subgroup analysis of the EMPEROR-Preserved clinical trial of the glucose-lowering drug empagliflozin in chronic heart failure with left ventricular ejection…”
    Get full text
    Journal Article